Gastroenterology and Liver

Pediatric and Adult Liver Metabolic Disorders

Metabolic liver disorders encompass a broad spectrum of genetic and acquired conditions affecting children and adults, including Wilson’s disease, hemochromatosis, and alpha-1 antitrypsin deficiency. This session will explore advances in understanding pathophysiology, early diagnosis, and innovative therapeutic approaches. Participants will gain insights into the role of genetic testing, metabolic profiling, and novel biomarkers in facilitating personalized care. Multidisciplinary strategies, including hepatology, genetics, nutrition, and transplantation, will be emphasized to optimize outcomes for affected patients.

The track also addresses emerging research in disease-modifying therapies, pharmacological interventions, and lifestyle management. Clinical trial data, long-term follow-up studies, and case reports will highlight real-world applications of diagnostic and therapeutic strategies. Participants will discuss challenges in managing pediatric versus adult populations, including growth, development, comorbidities, and quality of life considerations. This session provides a platform for researchers and clinicians to present innovative solutions and collaborate on advancing care for metabolic liver disorders.